Penn Medicine Current Advances in Heart and Vascular Care 2026

Latest Innovations in Cardiovascular Medicine, Vascular Care & Minimally Invasive Therapies

Penn Medicine Current Advances in Heart and Vascular Care 2026 is a cutting-edge cardiovascular education program designed to provide healthcare professionals with the latest updates in heart and vascular disease prevention, diagnosis, and treatment. This comprehensive course explores emerging technologies, minimally invasive cardiovascular interventions, artificial intelligence in healthcare, advanced risk assessment strategies, and novel therapies for complex cardiovascular conditions.

Held on February 28, 2026, this educational activity brings together leading experts from Penn Medicine to discuss contemporary challenges and future directions in cardiovascular and vascular medicine. The program focuses on practical, evidence-based approaches that can be immediately incorporated into clinical practice to improve patient outcomes.

Special emphasis is placed on cardiovascular prevention, lipoprotein(a) management, obesity and weight reduction strategies, hypertension, amyloidosis, peripartum cardiomyopathy, minimally invasive procedures, and the growing role of artificial intelligence in cardiovascular care.

Course Overview

Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, making ongoing education essential for healthcare professionals involved in cardiovascular care. This program provides a multidisciplinary review of current advances in cardiology, vascular surgery, interventional cardiology, preventive cardiology, and cardiovascular imaging.

Participants will gain valuable insight into evolving treatment paradigms, patient selection for advanced therapies, innovative procedural techniques, and the integration of technology-driven solutions into cardiovascular practice.

The course is designed to bridge the gap between emerging research and real-world patient care while addressing some of the most pressing challenges facing modern cardiovascular medicine.

Learning Objectives

Upon completion of this course, participants will be able to:

• Recognize effective strategies for cardiovascular disease prevention.
• Describe the clinical significance of lipoprotein(a) [Lp(a)] in cardiovascular risk assessment.
• Evaluate recent evidence regarding vaping and cardiovascular health.
• Identify patients who may benefit from weight management and obesity interventions.
• Recognize non-cardiac manifestations of amyloidosis.
• Implement contemporary approaches to hypertension management.
• Discuss the diagnosis and treatment of peripartum cardiomyopathy.
• Evaluate ethical considerations surrounding artificial intelligence in healthcare.
• Understand emerging AI-driven tools in cardiovascular medicine.
• Assess patient selection criteria for combined cardiovascular procedures.
• Apply new evidence-based treatment strategies in heart and vascular disease.

Key Topics Covered

Preventive Cardiology

• Cardiovascular risk reduction
• Primary prevention strategies
• Secondary prevention approaches
• Lifestyle interventions
• Population health initiatives

Lipoprotein(a) and Cardiovascular Risk

• Role of Lp(a) in atherosclerosis
• Risk stratification
• Screening recommendations
• Emerging therapies targeting Lp(a)

Vaping and Cardiovascular Disease

• Cardiovascular effects of vaping
• Emerging clinical evidence
• Public health implications
• Patient counseling strategies

Obesity and Weight Management

• Obesity-related cardiovascular disease
• Medical weight loss therapies
• GLP-1 receptor agonists
• Cardiometabolic risk reduction

Amyloidosis

• Cardiac amyloidosis recognition
• Non-cardiac manifestations
• Diagnostic evaluation
• Contemporary treatment options

Hypertension Management

• Resistant hypertension
• Advanced treatment approaches
• Risk reduction strategies
• Evidence-based blood pressure management

Peripartum Cardiomyopathy

• Risk factors and diagnosis
• Clinical management
• Long-term outcomes
• Pregnancy-related cardiovascular disease

Artificial Intelligence in Cardiovascular Medicine

• AI-assisted diagnostics
• Clinical decision support systems
• Ethical considerations
• Future applications of AI in patient care

Minimally Invasive Cardiovascular Therapies

• Advanced catheter-based interventions
• Structural heart procedures
• Combined cardiovascular procedures
• Patient selection and outcomes

Vascular Medicine & Surgery

• Contemporary vascular disease management
• Endovascular treatment strategies
• Vascular risk assessment
• Multidisciplinary vascular care

Who Should Attend?

This program is ideal for:

• Cardiologists
• Interventional Cardiologists
• Cardiovascular Surgeons
• Vascular Surgeons
• Internal Medicine Physicians
• Family Medicine Physicians
• Emergency Medicine Physicians
• Interventional Radiologists
• Diagnostic Radiologists
• Pediatric Cardiologists
• Nurse Practitioners
• Physician Assistants
• Residents and Fellows
• Healthcare professionals involved in cardiovascular care

Why This Course Stands Out

✔ Latest 2026 cardiovascular medicine updates

✔ Focus on preventive cardiology and risk reduction

✔ Emerging therapies for lipoprotein(a)

✔ Obesity and cardiometabolic disease management

✔ Amyloidosis and rare cardiovascular disorders

✔ Artificial intelligence applications in healthcare

✔ Minimally invasive cardiovascular interventions

✔ Vascular surgery and vascular medicine updates

✔ Multidisciplinary cardiovascular approach

✔ Evidence-based clinical practice recommendations

4. Topics

1. Amyloidosis- Diagnosis, Progression, and Patient Outcomes

2. Aneurysm Management and Repair- Minimally Invasive Solutions

3. Artificial Intelligence in Healthcare- Innovation Meets Patient Care

4. Cardiac Risk Factors and Tools for Risk Assessment

5. Cardiac Risk in Pregnancy- Evidence-Based Strategies for Clinicians

6. Cardiology Insights- How Weight Loss Improves Heart Function

7. Case Review- A Hole Lot of Trouble- A Post-MI VSD

8. Opening Remarks-Greeting

9. Optimizing Atrial Fibrillation Treatment- A Dual-Procedure Approach

10. Protecting the Protectors- A Cardiovascular Screening Initiative for First Responders

11. Renal Denervation- A New Path for Hypertension Care

12. Understanding Lp(a)- The Silent Heart Risk

13. Vaping and Heart Health- What the Research Shows